103 related articles for article (PubMed ID: 20226902)
21. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
Arthan D; Hong SK; Park JI
Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
[TBL] [Abstract][Full Text] [Related]
22. Xanthohumol induces generation of reactive oxygen species and triggers apoptosis through inhibition of mitochondrial electron transfer chain complex I.
Zhang B; Chu W; Wei P; Liu Y; Wei T
Free Radic Biol Med; 2015 Dec; 89():486-97. PubMed ID: 26453927
[TBL] [Abstract][Full Text] [Related]
23. Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.
Greenblatt DY; Cayo MA; Adler JT; Ning L; Haymart MR; Kunnimalaiyaan M; Chen H
Ann Surg; 2008 Jun; 247(6):1036-40. PubMed ID: 18520232
[TBL] [Abstract][Full Text] [Related]
24. 2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells.
Kim SY; Lee IS; Moon A
Chem Biol Interact; 2013 May; 203(3):565-72. PubMed ID: 23562496
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
[TBL] [Abstract][Full Text] [Related]
26. Antioxidant and antiproliferative activity of glycosides obtained by biotransformation of xanthohumol.
Tronina T; Bartmańska A; Milczarek M; Wietrzyk J; Popłoński J; Rój E; Huszcza E
Bioorg Med Chem Lett; 2013 Apr; 23(7):1957-60. PubMed ID: 23466227
[TBL] [Abstract][Full Text] [Related]
27. The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer.
Kebebew E; Treseler PA; Duh QY; Clark OH
Surgery; 2000 Dec; 128(6):952-7. PubMed ID: 11114629
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.
Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
J Surg Res; 2010 Apr; 159(2):640-4. PubMed ID: 19394967
[TBL] [Abstract][Full Text] [Related]
29. Fungal metabolites of xanthohumol with potent antiproliferative activity on human cancer cell lines in vitro.
Tronina T; Bartmańska A; Filip-Psurska B; Wietrzyk J; Popłoński J; Huszcza E
Bioorg Med Chem; 2013 Apr; 21(7):2001-6. PubMed ID: 23434138
[TBL] [Abstract][Full Text] [Related]
30. Xanthohumol modulates the expression of osteoclast-specific genes during osteoclastogenesis in RAW264.7 cells.
Suh KS; Rhee SY; Kim YS; Lee YS; Choi EM
Food Chem Toxicol; 2013 Dec; 62():99-106. PubMed ID: 23994090
[TBL] [Abstract][Full Text] [Related]
31. The inhibitory effects of xanthohumol, a prenylated chalcone derived from hops, on cell growth and tumorigenesis in human pancreatic cancer.
Jiang W; Zhao S; Xu L; Lu Y; Lu Z; Chen C; Ni J; Wan R; Yang L
Biomed Pharmacother; 2015 Jul; 73():40-7. PubMed ID: 26211581
[TBL] [Abstract][Full Text] [Related]
32. Cellular effects of imatinib on medullary thyroid cancer cells harboring multiple endocrine neoplasia Type 2A and 2B associated RET mutations.
de Groot JW; Plaza Menacho I; Schepers H; Drenth-Diephuis LJ; Osinga J; Plukker JT; Links TP; Eggen BJ; Hofstra RM
Surgery; 2006 Jun; 139(6):806-14. PubMed ID: 16782438
[TBL] [Abstract][Full Text] [Related]
33. Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions.
Chen H; Biel MA; Borges MW; Thiagalingam A; Nelkin BD; Baylin SB; Ball DW
Cell Growth Differ; 1997 Jun; 8(6):677-86. PubMed ID: 9186001
[TBL] [Abstract][Full Text] [Related]
34. Pitfalls in cell culture work with xanthohumol.
Motyl M; Kraus B; Heilmann J
Pharmazie; 2012 Jan; 67(1):91-4. PubMed ID: 22393838
[TBL] [Abstract][Full Text] [Related]
35. Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells.
Dorn C; Weiss TS; Heilmann J; Hellerbrand C
Int J Oncol; 2010 Feb; 36(2):435-41. PubMed ID: 20043079
[TBL] [Abstract][Full Text] [Related]
36. Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro.
Ferrari SM; Fallahi P; La Motta C; Bocci G; Corrado A; Materazzi G; Galleri D; Piaggi S; Danesi R; Da Settimo F; Miccoli P; Antonelli A
Surgery; 2014 Nov; 156(5):1167-76. PubMed ID: 25151558
[TBL] [Abstract][Full Text] [Related]
37. Xanthohumol attenuates tumour cell-mediated breaching of the lymphendothelial barrier and prevents intravasation and metastasis.
Viola K; Kopf S; Rarova L; Jarukamjorn K; Kretschy N; Teichmann M; Vonach C; Atanasov AG; Giessrigl B; Huttary N; Raab I; Krieger S; Strnad M; de Martin R; Saiko P; Szekeres T; Knasmüller S; Dirsch VM; Jäger W; Grusch M; Dolznig H; Mikulits W; Krupitza G
Arch Toxicol; 2013 Jul; 87(7):1301-12. PubMed ID: 23503627
[TBL] [Abstract][Full Text] [Related]
38. The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cells.
Kushchayeva Y; Jensen K; Recupero A; Costello J; Patel A; Klubo-Gwiezdzinska J; Boyle L; Burman K; Vasko V
J Clin Endocrinol Metab; 2014 May; 99(5):E734-45. PubMed ID: 24483157
[TBL] [Abstract][Full Text] [Related]
39. Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO).
Yin F; Giuliano AE; Van Herle AJ
Anticancer Res; 1999; 19(5B):4297-303. PubMed ID: 10628390
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
